Hartland & Co »

Cullinan Oncology shares owned by Hartland & Co

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $291 49 5.94

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
Vanguard Group
Deerfield Management Company
Blue Owl Capital Holdings
Kynam Capital Management
Citadel Advisors
OrbiMed Advisors
Rtw Investments
State Street Corporation
Franklin Resources
VR Adviser
Geode Capital Management

View all funds holding Cullinan Oncology